サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423211

心血管インプラント市場レポート：製品タイプ、材料、施術タイプ、適応症、地域別、2024年～2032年

Cardiovascular Implants Market Report by Product Type, Material, Procedure Type, Indication, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
心血管インプラント市場レポート：製品タイプ、材料、施術タイプ、適応症、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心血管インプラント市場規模は2023年に261億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに433億米ドルに達し、2024年から2032年の間に5.6％の成長率（CAGR）を示すと予測しています。心血管疾患の有病率の上昇、老年人口の拡大、ヘルスケア分野における著しい進歩が、市場を牽引する主な要因のいくつかです。

心血管インプラントは、心不全、冠動脈疾患、末梢動脈疾患、大動脈疾患、心筋梗塞など、さまざまな心血管疾患（CVD）の治療に使用される特殊な医療器具です。心臓や血管の適切な機能をサポートし、心臓の異常なリズムに伴う症状を緩和するために体内に装着されます。これらの器具は、チタン、熱分解カーボン、シリコーン、プラスチックメッシュで作られ、植込み型除細動器（ICD）発生器とポリウレタン（PU）ポリマーで絶縁されたワイヤーを備えています。心血管インプラントは、重度の心臓リズムを検出し、正常な心臓機能を維持するための信号を送ることができます。

本レポートで扱う主な質問

  • 世界の心血管インプラント市場の規模は？
  • 2024-2032年の世界の心血管インプラント市場の予想成長率は？
  • 世界の心血管インプラント市場を牽引する主要因は何か？
  • COVID-19が世界の心血管インプラント市場に与えた影響は？
  • 製品タイプ別の心血管インプラントの世界市場の内訳は？
  • 適応症別の心血管インプラントの世界市場の内訳は？
  • 世界の心血管インプラント市場の主要地域は？
  • 心血管インプラントの世界市場における主要企業/プレーヤーは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 心血管インプラントの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品タイプ別
  • 市場内訳：材料別
  • 市場内訳：施術タイプ別
  • 市場内訳：適応症別
  • 市場内訳：地域別
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 冠動脈ステント
    • 市場動向
    • 市場予測
  • ICD市場
    • 市場動向
    • 市場予測
  • 心臓弁
    • 市場動向
    • 市場予測
  • 植込み型心臓ペースメーカー
    • 市場動向
    • 市場予測
  • CRTデバイス
    • 市場動向
    • 市場予測
  • 末梢ステント
    • 市場動向
    • 市場予測

第7章 市場内訳：材料別

  • 金属・合金
    • 市場動向
    • 市場予測
  • ポリマー
    • 市場動向
    • 市場予測
  • バイオ材料
    • 市場動向
    • 市場予測

第8章 市場内訳：施術タイプ別

  • 血管形成術
    • 市場動向
    • 市場予測
  • 開心術
    • 市場動向
    • 市場予測

第9章 市場内訳：適応症別

  • 不整脈
    • 市場動向
    • 市場予測
  • 心筋虚血
    • 市場動向
    • 市場予測
  • 急性心筋梗塞
    • 市場動向
    • 市場予測
  • うっ血性心不全
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測

第11章 世界の心血管インプラント産業SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 世界の心血管インプラント産業：バリューチェーン分析

第13章 世界の心血管インプラント産業：ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 世界の心血管インプラント産業：価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BIOTRONIK SE & Co. KG
    • Abbott Laboratories
    • AMG International
    • B. Braun Melsungen AG
    • Johnson & Johnson Services, Inc.
    • W. L. Gore & Associates, Inc.
    • Medtronic Private Limited
    • Boston Scientific Corporation
    • Sorin Corporation
    • Edwards Lifesciences Corporation
    • Fortimedix Surgical B.V.
    • Neovasc Inc.
    • CryoLife Inc.
    • Proxy Biomedical Ltd.
    • REVA Medical, LLC.
    • Shree Pacetronix Ltd.
図表

List of Figures

  • Figure 1: Global: Cardiovascular Implants Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiovascular Implants Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Cardiovascular Implants Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Cardiovascular Implants Market: Breakup by Material (in %), 2023
  • Figure 5: Global: Cardiovascular Implants Market: Breakup by Procedure Type (in %), 2023
  • Figure 6: Global: Cardiovascular Implants Market: Breakup by Indication (in %), 2023
  • Figure 7: Global: Cardiovascular Implants Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Cardiovascular Implants Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Cardiovascular Implants Industry: SWOT Analysis
  • Figure 10: Global: Cardiovascular Implants Industry: Value Chain Analysis
  • Figure 11: Global: Cardiovascular Implants Industry: Porter's Five Forces Analysis
  • Figure 12: Global: Cardiovascular Implants (Coronary Stent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Cardiovascular Implants (Coronary Stent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Cardiovascular Implants (ICD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Cardiovascular Implants (ICD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Cardiovascular Implants (Heart Valve) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Cardiovascular Implants (Heart Valve) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Cardiovascular Implants (CRT Device) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Cardiovascular Implants (CRT Device) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Cardiovascular Implants (Peripheral Stent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Cardiovascular Implants (Peripheral Stent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Cardiovascular Implants (Metals and Alloys) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Cardiovascular Implants (Metals and Alloys) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Cardiovascular Implants (Polymers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Cardiovascular Implants (Polymers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Cardiovascular Implants (Biological Materials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Cardiovascular Implants (Biological Materials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Cardiovascular Implants (Angioplasty) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Cardiovascular Implants (Angioplasty) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Cardiovascular Implants (Open Heart Surgery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Cardiovascular Implants (Open Heart Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Cardiovascular Implants (Arrhythmias) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Cardiovascular Implants (Arrhythmias) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Cardiovascular Implants (Myocardial Ischemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Cardiovascular Implants (Myocardial Ischemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Cardiovascular Implants (Congestive Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Cardiovascular Implants (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Cardiovascular Implants (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Cardiovascular Implants (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: North America: Cardiovascular Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: North America: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Cardiovascular Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Asia Pacific: Cardiovascular Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Asia Pacific: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Middle East and Africa: Cardiovascular Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Middle East and Africa: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Latin America: Cardiovascular Implants Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Latin America: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Cardiovascular Implants Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Cardiovascular Implants Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Cardiovascular Implants Market Forecast: Breakup by Material (in Million US$), 2024-2032
  • Table 4: Global: Cardiovascular Implants Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
  • Table 5: Global: Cardiovascular Implants Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 6: Global: Cardiovascular Implants Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cardiovascular Implants Market Structure
  • Table 8: Global: Cardiovascular Implants Market: Key Players
目次
Product Code: SR112024A1164

Abstract

The global cardiovascular implants market size reached US$ 26.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 43.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector represent some of the key factors driving the market.

Cardiovascular implants are specialized medical tools used to treat various cardiovascular diseases (CVDs), including heart failure, coronary artery disease, peripheral arterial disease, aortic disease, and myocardial infarction. They are fitted inside the body to support the proper functioning of the heart and blood vessels and to alleviate symptoms associated with abnormal heart rhythms. These devices are made from titanium, pyrolytic carbon, silicone, and plastic mesh and are equipped with an implantable cardioverter-defibrillator (ICD) generator and wires that are insulated with polyurethane (PU) polymer. Cardiovascular implants can detect severe heart rhythms and send signals to maintain normal heart function.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type, material, procedure type and indication.

Product Type Insights:

Coronary Stent

ICD

Heart Valve

Implanted Cardiac Pacemaker

CRT Device

Peripheral Stent

The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the product type. This includes coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device, and peripheral stent. According to the report, ICD represented the largest segment.

Material Insights:

Metals and Alloys

Polymers

Biological Materials

A detailed breakup and analysis of the cardiovascular implants market based on the material has also been provided in the report. This includes metals and alloys, polymers, and biological materials.

Procedure Type Insights:

Angioplasty

Open Heart Surgery

The report has provided a detailed breakup and analysis of the cardiovascular implants market based on the procedure type. This includes angioplasty and open heart surgery.

Indication Insights:

Arrhythmias

Myocardial Ischemia

Acute Myocardial Infarction

Congestive Heart Failure

Others

A detailed breakup and analysis of the cardiovascular implants market based on the indication type has also been provided in the report. This includes arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure, and others. According to the report, arrhythmias accounted for the largest market share.

Regional Insights:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for cardiovascular implants. Some of the factors driving the North America cardiovascular implants market included the rising prevalence of CVDs, innovative product advancements, and the growing geriatric population.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cardiovascular implants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include BIOTRONIK SE & Co. KG, Abbott Laboratories, AMG International, B. Braun Melsungen AG, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Medtronic Private Limited, Boston Scientific Corporation, Sorin Corporation, Edwards Lifesciences Corporation, Fortimedix Surgical B.V., Neovasc Inc., CryoLife Inc., Proxy Biomedical Ltd., REVA Medical, LLC., and Shree Pacetronix Ltd.

Key Questions Answered in This Report

  • 1. How big is the global cardiovascular implants market?
  • 2. What is the expected growth rate of the global cardiovascular implants market during 2024-2032?
  • 3. What are the key factors driving the global cardiovascular implants market?
  • 4. What has been the impact of COVID-19 on the global cardiovascular implants market?
  • 5. What is the breakup of the global cardiovascular implants market based on the product type?
  • 6. What is the breakup of the global cardiovascular implants market based on the indication?
  • 7. What are the key regions in the global cardiovascular implants market?
  • 8. Who are the key players/companies in the global cardiovascular implants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiovascular Implants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Material
  • 5.6 Market Breakup by Procedure Type
  • 5.7 Market Breakup by Indication
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Coronary Stent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 ICD
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Heart Valve
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Implanted Cardiac Pacemaker
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 CRT Device
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Peripheral Stent
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Material

  • 7.1 Metals and Alloys
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Polymers
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biological Materials
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Procedure Type

  • 8.1 Angioplasty
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Open Heart Surgery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Indication

  • 9.1 Arrhythmias
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Myocardial Ischemia
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Acute Myocardial Infarction
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Congestive Heart Failure
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Global Cardiovascular Implants Industry: SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Global Cardiovascular Implants Industry: Value Chain Analysis

13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Global Cardiovascular Implants Industry: Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BIOTRONIK SE & Co. KG
    • 15.3.2 Abbott Laboratories
    • 15.3.3 AMG International
    • 15.3.4 B. Braun Melsungen AG
    • 15.3.5 Johnson & Johnson Services, Inc.
    • 15.3.6 W. L. Gore & Associates, Inc.
    • 15.3.7 Medtronic Private Limited
    • 15.3.8 Boston Scientific Corporation
    • 15.3.9 Sorin Corporation
    • 15.3.10 Edwards Lifesciences Corporation
    • 15.3.11 Fortimedix Surgical B.V.
    • 15.3.12 Neovasc Inc.
    • 15.3.13 CryoLife Inc.
    • 15.3.14 Proxy Biomedical Ltd.
    • 15.3.15 REVA Medical, LLC.
    • 15.3.16 Shree Pacetronix Ltd.